
The U.S. Food and Drug Administration (FDA) voted in support of the benefit-risk profile of Lumisight (pegulicianine), an imaging enhancement agent used with the Lumicell fluorescent-guided imaging system.
Read More

The U.S. Food and Drug Administration (FDA) voted in support of the benefit-risk profile of Lumisight (pegulicianine), an imaging enhancement agent used with the Lumicell fluorescent-guided imaging system.
Read More
LET US PROVIDE YOU WITH THE LATEST MEDICAL NEWS, NETWORKING AND PROFESSIONAL DEVELOPMENT OPPORTUNITIES, AND EXCITING JOB OPENINGS FOR RADIOLOGISTS.
"*" indicates required fields
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
Preferences
Our team will contact you soon.

